Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Synthetic Blood International, Inc. (SYBD) -- Ignore unavailable to you. Want to Upgrade?

To: Rick Hoffmann who wrote (48)	5/11/1999 11:57:00 PM
From: Micro-Selector	Respond to of 91

I'd say what will give them some "kinetic" energy is the synergy of many developments coming together this year. 1. funding for clinical trials 2. final of three patents 3. (potential) partner in S. Korea 4. being last of "synthetic blood" developers to enter clinical trials phase (benefit from past mistakes/failures of earlier attempts to get FDA approval) 5. benefit of seeking FDA approval for three products simultaneously (if one fails, can still generate revenues and market recognition from one or more of the others) Let's go SYBD!!! <-- (that's about as peppy as I get) Micro